Resumen

RICO-MESA, Juan Simon et al. Subcutaneous implantable defibrillator: a therapeutic alternative for prevention of sudden cardiac death. Rev. Mex. Cardiol [online]. 2017, vol.28, n.4, pp.189-199. ISSN 0188-2198.

The transvenous implantable cardiac defibrillator (T-ICD) is currently considered the standard of care for prevention of sudden cardiac death in patients with structural cardiac disease or channelopathies. However, the use of these devices is associated with a significant increase of short and long-term complications, mostly related to intravascular leads. The subcutaneous implantable cardiac defibrillator (S-ICD) is a novel alternative for high-risk patients susceptible to intravascular lead complications, with a similar efficacy as T-ICD. Multiple ongoing clinical trials involving the S-ICD are expected to provide additional information about safety, use and benefits in the clinical setting.

Palabras llave : Implantable cardiac defibrillator; subcutaneous; safety; efficacy.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )